BaroSense Inc. is a medical device company headquartered in Redwood City, CA, that focuses on the research and development of innovative, minimally invasive medical devices for the treatment of obesity - the largest global chronic disease in adults.

It is estimated that more than 300 million people suffer from obesity worldwide. Obesity has reached epidemic proportions in the United States, affecting approximately 60 million adults. Estimates for obesity related deaths currently attribute over 300,000 deaths a year in the United States to the disease. Obese individuals are at an increased risk for diabetes, coronary heart disease, stroke, sleep apnea, gall bladder disease, several types of cancer, and certain musculoskeletal disorders. All told obesity is one of the most significant issues facing our healthcare system and society in general.

BaroSense is committed to the development of minimally invasive therapeutic weight loss procedures and devices. These innovative procedures and devices are intended to provide a meaningful contribution to those seeking to improve health status by losing excess weight. The BaroSense products and procedures create a safe, simple, effective and reversible alternative to the surgical treatment of obesity. BaroSense offers a less invasive approach to assist those people who want to get more out of lifestyle change programs, and who wish to avoid extensive and irreversible surgical procedures.

BaroSense's goal is to bring less invasive treatments to those suffering with obesity so that they may experience more in their lives.
obesity weight loss surgery
Learn more about your treatment options and if you are a candidate for traditional or investigational treatments.
more »
obesity treatments
Find out about the Investigational TERIS procedure and how the TERIS procedure and treatment might benefit your patients.
more »
  Coming soon...
Home | Patients | Physicians | About Us | News & Events | Careers | Contact Us | Site Map | Legal
© 2010 Barosense, Inc. All rights reserved.
Designed by: